MPM
COLL icon

Meritage Portfolio Management’s Collegium Pharmaceutical COLL Stock Holding History

Meritage Portfolio Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,755
Closed -$595K – 326
2024
Q4 		$595K Buy
20,755
+979
+5% +$32.4K 0.04% 239
2024
Q3 		$764K Buy
+19,776
New +$705K 0.05% 222
2024
Q2 		– Sell
-8,141
Closed -$316K – 336
2024
Q1 		$316K Buy
+8,141
New +$285K 0.02% 290

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Meritage Portfolio Management's COLL Position: Q1 2025 in Review

Meritage Portfolio Management sold out of Collegium Pharmaceutical (COLL) in Q1 2025, closing a stake of 20,755 shares — an estimated $595K sold.

Meritage Portfolio Management first reported a position in COLL in Q1 2024 and held it in 3 quarters. The position peaked at $764K in Q3 2024. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

  • Meritage Portfolio Management reported no remaining Collegium Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Meritage Portfolio Management sold 20,755 Collegium Pharmaceutical shares in Q1 2025, an estimated $595K.
  • Meritage Portfolio Management first reported a position in Collegium Pharmaceutical in Q1 2024 and held it in 3 quarters.
  • Meritage Portfolio Management's Collegium Pharmaceutical position peaked at $764K in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on Meritage Portfolio Management's 13F filing for Q1 2025, filed 28 Apr 2025.